Related Experiment Video
Updated: May 21, 2025

Cellular Lipid Extraction for Targeted Stable Isotope Dilution Liquid Chromatography-Mass Spectrometry Analysis
Published on: November 17, 2011
Novel 5,6-Fused and 6,6-Fused Bicyclic Compounds as 15-Prostaglandin Dehydrogenase Modulators
1Department of Radiology and Imaging Sciences, Emory University, Atlanta, Georgia 30322, United States.
Abstract:
This patent highlight describes novel substituted 5,6-fused and 6,6-fused bicyclic compounds as 15-prostaglandin dehydrogenase (15-PGDH) modulators. It provides a detailed account of their synthesis, pharmaceutical composition, and potential use in the treatment for 15-PGDH-related diseases, such as intestinal, gastrointestinal, or bowel disorders.
More Related Videos
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Diels–Alder Reaction Forming Bridged Bicyclic Products: Stereochemistry
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Stability of Conjugated Dienes
A comparison of the enthalpies of hydrogenation of dienes reveals that conjugated dienes release less heat on hydrogenation, rendering them more stable than their nonconjugated analogs.
[4+2] Cycloaddition of Conjugated Dienes: Diels–Alder Reaction

